Trial intelligence / Profile preview

Prophylaxis of surgical wound infection with topical antibiotics

2017-002669-23Phase 3Completed

Sponsor
Hospital General Universitari de Granollers
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of amoxicillin + clavulanate in surgical site infection (SSI) and bacterial wound infection (2 arms), sponsored by Hospital General Universitari de Granollers. Primary endpoint: Presence of surgical infection within 30 days after surgery. Started Dec 2017; status: completed.

02

Drugs

amoxicillin + clavulanate
03

Conditions

surgical site infection (SSI)bacterial wound infection

Beyond the preview

Go deeper on 2017-002669-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002669-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call